Dear venture capitalists: You’re blowing it
The asset class is at risk if VC funds don’t take more companies public.
The asset class is at risk if VC funds don’t take more companies public.
Root exudation could be harnessed for ecological and applied research
The most comprehensive look at genetic differences among flowering plants suggests ancient interbreeding confounded relationships between dogwoods and blueberries, among others
It is the first time since the Oct. 7 attack that the U.S. has stopped a weapons shipment intended for the Israeli military.
The Federal Trade Commission (FTC) recently announced two proposed settlement agreements (in the form of a stipulated order) (the “consent orders”) with Monument, Inc., an alcohol addiction…
Our latest report looks at the current state of R&D returns for 20 leading biopharma companies; how to streamline clinical trials, optimize pipeline value, and…
The Apple Watch AFib feature has already been credited with saving lives.
Tiny crystals grown within molten metals at atmospheric pressure
General Catalyst, Providence’s venture arm and 7WireVentures were among the notable digital health investors this week.
Effective leaders embrace the complexities of AI, recognize the limits of control and take steps to anticipate and manage risks.
Marcus Munafò, our new Associate Editor for Research, on credibility in how psychologists report results.